Literature DB >> 19908648

Communication and documentation considerations for electronic health records.

Ann D Gaffey1.   

Abstract

Electronic health records (EHRs) are here to stay, and their use is expected to grow significantly in the future. It is incumbent on risk managers to ensure their use does not inhibit good provider-to-patient communication. Providing education and strategies on how to make the patient encounter meaningful while the provider uses an EHR may increase patient satisfaction and may contribute to a favorable professional liability loss experience. Risk managers also need to have an understanding of the capabilities of each specific EHR system in the facility, the implications of the ability to cut-and-paste information from one provider entry to another, and knowledge of how to control the risk that comes with both copying forward and delayed EHR documentation.

Entities:  

Mesh:

Year:  2009        PMID: 19908648     DOI: 10.1002/jhrm.20010

Source DB:  PubMed          Journal:  J Healthc Risk Manag        ISSN: 1074-4797


  4 in total

1.  A qualitative analysis evaluating the purposes and practices of clinical documentation.

Authors:  Y-X Ho; C S Gadd; K L Kohorst; S T Rosenbloom
Journal:  Appl Clin Inform       Date:  2014-02-26       Impact factor: 2.342

2.  Overview of laboratory data tools available in a single electronic medical record.

Authors:  Neil R Kudler; Liron Pantanowitz
Journal:  J Pathol Inform       Date:  2010-05-26

3.  Developing an evidence base of best practices for integrating computerized systems into the exam room: a systematic review.

Authors:  Minal R Patel; Jennifer Vichich; Ian Lang; Jessica Lin; Kai Zheng
Journal:  J Am Med Inform Assoc       Date:  2017-04-01       Impact factor: 4.497

4.  Computerized provider documentation: findings and implications of a multisite study of clinicians and administrators.

Authors:  Peter J Embi; Charlene Weir; Efthimis N Efthimiadis; Stephen M Thielke; Ashley N Hedeen; Kenric W Hammond
Journal:  J Am Med Inform Assoc       Date:  2013-01-25       Impact factor: 4.497

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.